Indian Pharma Market Kicks Off 2026 With 10% Growth in January: PharmaTrac Written By Susmita Roy12 Feb 2026 11:54 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) started calendar year 2026 with a robust uptick, delivering 10.21% month-on-month value growth and...
Dr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment Written By Susmita Roy6 Nov 2025 3:17 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Dr. Reddy's...
Game-Changer for HIV: Dr Reddy's, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year Farhat Nasim25 Sept 2025 3:51 PM ISTBengaluru: Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly...
Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor Written By Dr Akhil Kapoor21 Aug 2025 12:30 PM ISTIn this video, Dr. Akhil Kapoor, Medical Oncologist at Tata Memorial Centre, Varanasi, Uttar Pradesh, discusses a real-world case study of...
Dr Reddy's Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream Parthika Patel7 Aug 2025 11:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Limited has received approval from the Subject Expert Committee (SEC) under CDSCO to conduct a Phase III clinical...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
CDSCO Panel Rejects Dr Reddy's Proposal to Study FDC of Ketorolac plus Serratiopeptidase Capsules Written By Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: Citing there is no rationality of the combination and significant benefits, the Subject Expert Committee (SEC) functional under the...
Determine efficacy of immunotherapy in PD-L1 negative and low patients: CDSCO Panel Tells Dr Reddy on Nivolumab Written By Dr. Divya Colin20 Jan 2024 5:30 PM ISTNew Delhi: Based on the Phase I/III clinical trial protocol of the anti-cancer drug Nivolumab presented by the drug major Dr Reddy Laboratories, the...
Conduct Phase III CT of Triptorelin to treat chronic pain linked to endometriosis: CDSCO Panel Tells Dr Reddy's Lab Written By Dr. Divya Colin11 Jan 2024 6:00 PM ISTNew Delhi: Citing that the pharmaceutical giant Dr. Reddy's Laboratories has not supplied data on the Indian population for the management and relief...
Dr. Reddy's Gets CDSCO Panel Nod to Study FDC Etoricoxib plus Thiocolchicoside for Export purpose Dr. Divya Colin1 Dec 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan Dr. Divya Colin15 April 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy's Laboratories, the Subject Expert...
Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report Farhat Nasim22 Nov 2022 6:36 PM ISTNew Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...
